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Brown fat can reduce obesity through the dissipation
of calories as heat. Control of thermogenic gene
expression occurs via the induction of various
coactivators, most notably PGC-1a. In contrast, the
transcription factor partner(s) of these cofactors
are poorly described. Here, we identify interferon
regulatory factor 4 (IRF4) as a dominant transcrip-
tional effector of thermogenesis. IRF4 is induced by
cold and cAMP in adipocytes and is sufficient to
promote increased thermogenic gene expression,
energy expenditure, and cold tolerance. Conversely,
knockout of IRF4 in UCP1+ cells causes reduced
thermogenic gene expression and energy expendi-
ture, obesity, and cold intolerance. IRF4 also induces
the expression of PGC-1a and PRDM16 and inter-
acts with PGC-1a, driving Ucp1 expression. Finally,
cold, b-agonists, or forced expression of PGC-1a
are unable to cause thermogenic gene expression
in the absence of IRF4. These studies establish
IRF4 as a transcriptional driver of a program of ther-
mogenic gene expression and energy expenditure.
INTRODUCTION
Although many creatures can produce heat, only eutherian
mammals possess brown adipocytes, specialized cells that
use uncoupling protein 1 (UCP1) to dissociate O2 consumption
from ATP synthesis. This highly thermogenic process consumes
large amounts of substrate (primarily fatty acids but also
glucose) and is activated by cold exposure, catecholamines,
and other stimuli (Villarroya and Vidal-Puig, 2013). Two different
UCP1+ cell types have been described, so-called ‘‘classic’’brown adipocytes, which are present at all times in the interscap-
ular region of rodents and a ‘‘recruitable’’ cell called the beige
adipocyte that develops within specific white adipose depots
when environmental conditions demand it (Wu et al., 2013).
These two UCP1+ cell types derive from different embryological
origins, and they express overlapping but distinct gene expres-
sion programs (Seale et al., 2008; Wu et al., 2012). The study
of human brown fat has undergone a dramatic renaissance
with the recent discovery that adults possess significant quanti-
ties of this tissue (Cypess et al., 2009; van Marken Lichtenbelt
et al., 2009; Virtanen et al., 2009), opening the door for therapeu-
tic manipulation of these cells in diabetes and obesity.
At the transcriptional level, most attention has fallen on various
cofactors, which lack DNA binding domains and thus must act
by docking on bona fide transcription factors. Among the best
studied of these are PGC-1a and Prdm16, the latter of which
acts through the transcription factors C/EBPb, PPARg, and
possibly others to promote brown and beige adipocyte identity
(Kajimura et al., 2008, 2009; Seale et al., 2007). PGC-1a has
been shown to coactivate PPARg and PPARa to promote brown
fat differentiation and fatty acid oxidation respectively; it drives
mitochondrial biogenesis, at least in part, via its actions on
ERRa (Wu and Boss, 2007). It is less clear, however, how the
thermogenic gene expression program is coactivated by PGC-
1a. For example, mice lacking ERRa have defects in mitochon-
drial number and function but still induce Ucp1 expression
appropriately when exposed to cold (Villena et al., 2007).
Similarly, PPARa null mice display defective fatty acid oxidation
but normal thermogenic gene expression, including Ucp1 (Xue
et al., 2005).
We have previously identified interferon regulatory factor 4
(IRF4) as an important regulator of adipogenesis and adipose
lipid handling (Eguchi et al., 2008, 2011). IRF4 expression is
induced by fasting in adipocytes via FoxO1 and is repressed
by insulin. Animals that lack IRF4 in adipose tissue are obese
and insulin resistant and are unable to fully mobilize lipid storesCell 158, 69–83, July 3, 2014 ª2014 Elsevier Inc. 69
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Figure 1. Irf4 Expression Is Induced by Cold
Exposure and b3-AR Agonist in Adipocytes
(A and B) qPCR and western blotting were per-
formed on mRNA and protein from fat depots of
C57BL/6 mice at room temperature (RT) or exposed
to 4C for 6 hr.
(C) qPCR was performed on mRNA from BAT of
C57BL/6 mice exposed to 4C for the indicated
lengths of time (n = 5).
(D) Mice were treated with CL316,243 for 6 hr prior
to tissue harvest and qPCR.
(E) SVF from inguinal fat was differentiated into
adipocytes ex vivo, treated with Forskolin for 4 hr,
and then analyzed by qPCR.
(F) 3T3-F442A adipocytes were differentiated and
cultured at 37C or 30C for 10 days followed by
harvest and qPCR.
(G) SVF from superficial and deep neck adipose
tissue depots from four human subjects were
differentiated into mature adipocytes and treated
for 4 hr with 500 mM dibutyryl-cAMP. For all parts,
*p < 0.05, expressed as mean ± SEM.in the face of catecholamine treatment or prolonged fasting
(Eguchi et al., 2011). Of note, these mice are also cold intolerant,
a phenotype ascribed at the time to reduced fatty acid substrate
required to fuel thermogenesis. Interestingly, however, we
also noted that some thermogenic gene expression, including
Ucp1, was reduced in the interscapular brown adipose tissue
(BAT) of these animals. This led to the suggestion that, in addition
to serving as a key regulator of lipolysis in both brown and white
adipose tissues, IRF4might also play a direct thermogenic role in
the latter.
Here, we show that IRF4 is transcriptionally regulated by cold
and cAMP in murine and human BAT prior to the induction of
Ucp1 and that mice that overexpress IRF4 transgenically in
BAT display enhanced thermogenic gene expression, energy
expenditure, and cold tolerance. Conversely, mice lacking
IRF4 specifically in UCP1+ cells are obese and insulin resistant
and display reduced thermogenic gene expression, cold toler-
ance, and energy expenditure. Importantly, IRF4 induces the
expression of both Ppargc1a and Prdm16 and physically inter-
acts with PGC-1a to induce Ucp1 expression. Finally, cold, cat-
echolamines, and forced expression of PGC-1a are unable to
induce thermogenic gene expression in the absence of IRF4.70 Cell 158, 69–83, July 3, 2014 ª2014 Elsevier Inc.Taken together, these studies demon-
strate that IRF4 acts as a dominant tran-
scriptional regulator of thermogenesis
via genetic and physical interactions with
PGC-1a.
RESULTS
Irf4 Expression Is Induced in Brown
Adipocytes by Cold and cAMP
Fasting induces Irf4 in both WAT and BAT
(Eguchi et al., 2011), and we wondered if
cold exposure might have a similar effect.
This proved to be the case, as 6 hr at 4C
increased both mRNA and protein levels of IRF4 in classical in-
terscapular brown fat as well as in inguinal and epididymal white
fat (Figures 1A and 1B). Time course analysis shows that this
effect occurs within an hour of cold exposure, coincident with
the induction of Ppargc1a and prior to Ucp1 (Figure 1C). Irf4
mRNA was also induced after the administration of the b3-
agonist CL-316,243 (Figure 1D). To test whether these effects
are cell autonomous, we harvested the stromal-vascular fraction
(SVF) from the brown fat pads of newborn mice and differenti-
ated them ex vivo; treatment of these cells with forskolin caused
a significant elevation in Irf4 mRNA levels (Figure 1E). Recently,
cultured 3T3-F442A adipocytes were shown to induce a thermo-
genic gene expression program when exposed directly to 30C
(Ye et al., 2013). We tested whether Irf4 expression is also sensi-
tive to this perturbation and found a modest but significant
induction by cold even in these isolated cells (Figure 1F), sug-
gesting the involvement of cell autonomous mechanisms that
do not require catecholamine signaling.
UCP1+ adipocytes have now been unequivocally identified in
adult humans (Cypess et al., 2009; van Marken Lichtenbelt
et al., 2009; Virtanen et al., 2009). There is still ambiguity over
whether these cells correspond to murine brown or beige fat,
with one study suggesting that more superficial neck deposits
are similar to beige, whereas deeper depots correspond to
classic brown fat (Cypess et al., 2013). We found that cAMP
treatment dramatically induced Irf4 mRNA expression in adipo-
cytes derived from both deep and superficial human depots
(Figure 1G).
Targeted Expression of IRF4 Causes Enhanced Energy
Expenditure and Leanness
Having established that IRF4 expression is elevated in the BAT
and WAT of cold-exposed animals, we asked whether IRF4 is
sufficient to promote thermogenesis. To this end, we developed
a line of knockin mice in which the IRF4 cDNA was inserted
downstream of the ROSA26 promoter and a loxP-Stop-loxP
cassette (R26-LSL-IRF4; Figure S1A available online). Crossing
these mice to Ucp1-Cre mice would then enable targeted over-
expression in brown adipocytes. Unfortunately, the available
Ucp1-promoter driven Cre line (Guerra et al., 2001) has problems
with both specificity and recombination efficiency. We thus
generated a Ucp1-Cre line using a BAC transgenic approach.
By inserting the Cre recombinase cassette into the starting
ATG of Ucp1 within a large bacterial artificial chromosome (Fig-
ure S1B), we ensured that the majority of the key regulatory ele-
ments would be in their native context. At room temperature,
these mice express Cre specifically in the interscapular brown
fat (Figure S1C). Cold exposure induces Cre expression in
inguinal and epididymal WAT in a time-dependent manner,
consistent with the onset of browning (Figure S1D). Importantly,
these mice do not have any obvious metabolic phenotype (Fig-
ures S1E, S1F, and S2A).
Mice that carry both the Ucp1-Cre and R26-LSL-IRF4 trans-
genes (hereafter designated as BAT IRF4 overexpressors, or
BATI4OE) exhibit moderate (5–103) overexpression of IRF4 in
BAT (Figures 2A and 2B), in the range of the induction seen
following exposure to cold or b-agonist. No overexpression is
seen in inguinal or epididymal depots at room temperature.
BATI4OE mice display significantly reduced body weight and
fat mass on both chow (Figures S2A and S2B) and high-fat diets
(HFDs) (Figures 2C and 2D). Both inguinal and epididymal depots
are smaller in BATI4OE mice and their adipocytes show less
hypertrophy on an HFD than those of control mice (Figures 2E,
2F, and S2C). Food intake did not differ between the genotypes
(Figure 2G), but BATI4OE mice had enhanced energy expendi-
ture (Figures 2H and 2I); physical activity was unchanged
(Figure S2D). In addition, we assessed the effect of IRF4 overex-
pression in BAT on glucose homeostasis and found that overex-
pressor mice have improved glucose and insulin tolerance
testing relative to controls on an HFD (Figures S2E and S2F).
IRF4 Expression Is Sufficient to Cause Enhanced
Thermogenesis in BAT
BATI4OEmice have smaller brown adipose depots (Figures S2C
and 3A) and reduced lipid stores in BAT at both room tempera-
ture and 4C (Figure 3B). This phenotypic change is accompa-
nied by increased expression of key thermogenic genes (e.g.,
Ucp1, Prdm16, and Ppargc1a) (Figures 3C and 3D). Fatty
acid oxidation genes (e.g., Ppara, Cpt1b) were also induced,
consistent with a trend toward increased palmitate oxidation inBATI4OE brown adipocytes tested ex vivo (Figure S2G). No
changewas seen in the expression of genes encodingmitochon-
drial proteins (Figure 3C), although some changes are seen in the
mitochondrial protein levels themselves (Figure S2H). Isolated
mitochondria from the BAT of BATI4OE mice display increased
uncoupled respiration (Figure 3E). General adipose markers
are unaffected in these mice, as were lipolysis genes (Figure 3F),
consistent with unaltered lipolysis in brown adipocytes ex vivo
and BATI4OE mice in vivo (Figures S2I and S2J). Interestingly,
lipogenesis was significantly reduced in brown adipocytes
from BATI4OE mice (Figure S2K), although genes like Fasn,
Srebf, and Scd1 are unaltered (Figure 3F). Consistent with the
changes in thermogenic gene expression, BATI4OE mice are
modestly but significantly better able to defend their body tem-
perature during an acute cold stress (Figure 3G).
We also assessedwhether overexpression of IRF4 could affect
the browning of white adipose depots. As expected, BATI4OE
mice do not show elevated IRF4 levels in inguinal WAT at room
temperature, as there is minimal Ucp1 expression in that condi-
tion and thus no recombination. Exposure to cold for 6 days
increased Irf4 expression in both control and BATI4OE mice
such that the final levels were equivalent in the two lines. Consis-
tent with this, we saw no difference in thermogenic gene expres-
sion or in the histological appearance of inguinal fat (Figures S3A
and S3B). In epididymal fat, however, we did see increased Irf4
expression in BATI4OE mice, accompanied by increased ther-
mogenic gene expression and a histological pattern consistent
with enhanced browning (Figures S3C and S3D).
Loss of IRF4 in Brown Fat Causes Reduced Energy
Expenditure and Predisposes to Obesity
It is well established that obese animals and humans show defi-
ciencies in BAT content and function (Ricquier et al., 1986; Saito
et al., 2009; Tokuyama and Himms-Hagen, 1986; van Marken
Lichtenbelt et al., 2009; Vijgen et al., 2011; Virtanen et al.,
2009), and consistent with this, we see reduced Irf4 expression
in the interscapular BAT of high-fat fed mice as well as in two
genetic models of obesity (ob/ob and db/db) (Figure 4A).
Of course this association does not prove causality, so we
generated animals lacking IRF4 specifically in BAT by crossing
our Ucp1-Cre line to Irf4flox/flox mice (Klein et al., 2006). The re-
sulting Irf4flox/flox;Cre+ animals (henceforth designated as BAT
IRF4 knockout, or BATI4KO) have remarkably little IRF4 mRNA
or protein left in the interscapular BAT at room temperature (Fig-
ures 4B and 4C), while other tissues, such as WAT and spleen,
show no change. Resident macrophages and T cells, which
express high levels of IRF4 but do not express Ucp1, likely
account for the small amount of residual IRF4 seen in BAT. On
chowdiet, male BATI4KOmice display a tendency toward higher
body weight (Figure S4A) and have a small but significant
increase in fat mass (Figure S4B). On an HFD, the BATI4KO
mice clearly have elevated body weight and adiposity (Figures
4D and 4E). The white adipose depots of BATI4KO mice are
hypertrophic relative to Irf4flox/flox;Cre littermates (Figures 4F,
4G, and S4C). The cause of the increased adiposity seen in
BATI4KO mice was not increased food intake, as this did not
differ between these mice and their controls (Figure 4H). Rather,
large reductions were seen in both oxygen consumption andCell 158, 69–83, July 3, 2014 ª2014 Elsevier Inc. 71
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Figure 2. Mice that Overexpress IRF4 in BAT (BATI4OE) Are Lean and Display Evidence of Enhanced Energy Expenditure
(A and B) IRF4 overexpression was verified in BATI4OE mice by qPCR and western blotting. Data are normalized to 36B4 and expressed as mean ± SEM (n = 4,
*p < 0.05). Control mice for all BATI4OE experiments are R26-LSL-IRF4;Cre.
(C) Body weight of BATI4OE mice on HFD (n = 9–16/group, *p < 0.05).
(D) Body composition of mice from (C) after 12 weeks of high-fat feeding (*p < 0.05).
(E) Gross morphology of BATI4OE mice (36 weeks old) and inguinal and epididymal fat pads after high-fat feeding.
(F) Hematoxylin and eosin staining of paraffin-embedded inguinal and epididymal WAT sections from 36-week-old mice (320).
(legend continued on next page)
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CO2 production (Figures 4I and 4J) without altered physical
activity (Figure S4D).
As would be predicted from their elevated body weight,
BATI4KO mice show worsened glucose and insulin tolerance
(Figures S4E and S4F). To determine whether this could be fully
ascribed to obesity, we repeated the glucose and insulin toler-
ance tests on mice exposed to an HFD for only 4 weeks, a
time point prior to the divergence in body weight. Thesemice still
showed significant glucose and insulin intolerance under these
conditions (Figures S4G and S4H), indicating that increased
body weight is not the primary driver of the metabolic defect.
Although some BATI4KO mice appeared to be longer than their
control littermates, this was not significant between the groups
as a whole (n = 8–11).
IRF4 Is Required for Normal Thermogenesis and
Mitochondrial Function in BAT
Reduced energy expenditure, obesity, and dysglycemia are all
hallmarks of deficient brown adipose function and suggest a
defect in thermogenic capacity. The interscapular brown adi-
pose depot from BATI4KO mice was grossly larger and showed
hypertrophic cells with increased lipid content at room tempera-
ture (Figures 5A, 5B, and S4C). At 4C, both genotypes showed
reduced lipid in BAT, although a significant difference was still
noted (Figure 5B). This was accompanied by a clear reduction
in the expression of genes associated with thermogenesis, elec-
tron transport, and fatty acid oxidation (Figures 5C and 5D). As
predicted by the gene expression changes, palmitate oxidation
in BATI4KO cells was significantly reduced (Figure S5A). In
accordance with our prior work (Eguchi et al., 2011), we saw
significant reductions in lipolytic gene expression, accompanied
by diminished lipolytic activity ex vivo and in vivo (Figures S5B
and S5C). As was seen in the overexpressor mice, lipogenic
activity was altered even though lipogenic gene expression
was not (Figures 5E and S5D).
BATI4KO mice show reduced mitochondrial respiration (Fig-
ures 5F and 5G) and gene expression (Figures 5C and S5E). At
the ultrastructural level, however, the mitochondria of BATI4KO
mice appear indistinguishable from their controls, both in terms
of overall number and in the density of cristae (Figures S5F–
S5H). We next exposed BATI4KO and control mice to 4C and
measured body temperature, to assess the physiological impor-
tance of these defects. As predicted, BATI4KO mice were less
able to defend their body temperature in the face of acute cold
stress (Figure 5H).
We also wished to assess the requirement for IRF4 in the
browning of white fat. We were concerned that our system is
not optimized to answer this question, because Cre-mediated
recombination will not occur until after cold drives the differen-
tiation of these cells (Wang et al., 2013). Despite this caveat,
however, BATI4KO mice exposed to 4C for 6 days display
reduced thermogenic and mitochondrial gene expression in(G) Food intake was measured daily after 3 weeks on HFD (n = 8), and cumulativ
(H and I) O2 consumption and CO2 production rates of BATI4OE and WT littermat
(n = 8; *p < 0.0001 for both).
See also Figures S1 and S2.their inguinal WAT relative to control mice (Figure S6A). This
was consistent with the cold-dependent appearance of small,
multilocular UCP1+ cells in control, but not BATI4KO mice (Fig-
ure S6B). No change was seen in the histological appearance or
gene expression pattern of epididymal fat in these mice (Figures
S6C and S6D).
Thermogenic Gene Expression Cannot Be Induced by
Cold or b-Agonists in the Absence of IRF4
Having determined that IRF4 is required for basal thermogenic
gene expression in brown and beige adipocytes, we next asked
whether this program could still be provoked in the absence of
IRF4. We first assessed this in cold-exposed animals, showing
that many thermogenic genes such as Ucp1, Dio2, and
Ppargc1a become induced in the interscapular BAT of floxed
control mice, but not BATI4KO mice (Figure 6A). Similarly, the
CL-316,243 induces a broad array of genes that promote ther-
mogenesis, fatty acid oxidation, and lipolysis in control mice,
while BATI4KO mice do not recapitulate this effect (Figure 6B).
PGC-1a and IRF4 Interact Genetically, Physically, and
Functionally
IRF4 is induced in BAT contemporaneously with PGC-1a (Fig-
ure 1C) and is required for the full expression of PGC-1a in
both the basal and stimulated states (Figures 5C, 6A, and 6B).
We next asked whether the converse is also true; is PGC-1a
required for Irf4 expression? We first looked at the BAT of mice
lacking Ppargc1a in adipose tissue (Kleiner et al., 2012) and
saw that, in fact, Irf4 mRNA levels were 1/3 of those seen in
wild-type (WT) control animals (Figure S7A). Furthermore, we
took SVF cells from the inguinal fat of these mice and differenti-
ated them ex vivo; treatment with forskolin caused a significant
induction of Irf4mRNA in wild-type cells that was severely blunt-
ed in cells lacking PGC-1a (Figure S7B). Together, these data
suggest that PGC-1a and IRF4 induce each other’s expression
in a mutually reinforcing loop.
We also asked whether IRF4 and PGC-1a interact physically.
The phenomenon in which a transcription factor induces the
expression of a coactivator and then interacts with that factor
to regulate downstream gene expression is considered a form
of feed-forward regulation (Alon, 2007; Wu et al., 1999). In a
coimmunoprecipitation assay in vitro, we found that PGC-1a
interacts strongly with IRF4 (Figure 7A). This could be recapitu-
lated in isolated brown adipocytes from cold-exposed mice,
demonstrating that the interaction occurs at normal levels of
these two proteins (Figure 7B). Furthermore, the interaction is
direct, as it occurs even in a GST pull-down assay in vitro (Fig-
ure 7C). Nuclear receptors, like PPARg and ERRa, interact with
PGC-1a via LXXLL motifs found in the N-terminal half of the
molecule (Huss et al., 2002; Schreiber et al., 2003). We used
various truncation mutants of PGC-1a to show that IRF4 docks
on the same part of the molecule (Figures S7C and S7D).e food intake was calculated after 3 days.
es were measured by indirect calorimetry using CLAMS after 4 weeks on HFD
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Figure 3. BATI4OE Mice Display Increased Thermogenic Gene Expression and Cold Tolerance
(A) Gross appearance of interscapular BAT from control and BATI4OE mice at RT.
(B) Hematoxylin and eosin staining of BAT sections from control and BATI4OE mice housed at 23C or 4C for 6 hr.
(C) Thermogenic, mitochondrial and fatty acid oxidation gene expression in BAT. RNAwas harvested fromBAT of BATI4OE and control littermates after 28weeks
on HFD at 23C. Gene expression was measured using qPCR. Data are normalized to 36B4 and expressed as mean ± SEM (n = 3-5, *p < 0.05).
(D) Western blot analysis of protein in BAT of mice from (C).
(legend continued on next page)
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Specifically, deletion of the second and third LXXLL motifs of
PGC-1a completely blocks the interactionwith IRF4 (Figure S7E).
IRF4, like other members of the IRF family, has a large C-terminal
region used for protein-protein interactions (IAD), such as with
PU.1 or other IRFs (Figure S7F) (Honda and Taniguchi, 2006).
Deletion of the IRF4 DBD does not disrupt the interaction with
PGC-1a, but removal of the IAD does (Figure S7G).
We also examined the 50 flanking region of the Ucp1 gene to
determine whether IRF4 might serve as a direct transcriptional
regulator. Computational analysis identified a consensus inter-
feron-stimulated response element (ISRE) located 1,251 base
pairs upstream of the transcriptional start site. A Ucp1 pro-
moter-luciferase construct transfected into 293 cells could be
activated independently by IRF4 and by PGC-1a and the two
together caused an additive induction (Figure 7D). A smaller
construct (1,727) that still contains the ISRE showed even
more impressive activation by PGC-1a and IRF4, suggesting
distal negative regulatory elements. However, deletion of the
ISRE abolished the induction of luciferase expression by IRF4,
PGC-1a, or both. Similar results were obtained when primary
BAT cells were used (Figure S7H). IRF4 binds to this site on
the Ucp1 promoter in BAT, as shown by chromatin immunopre-
cipitation (Figure 7E).
Finally, we forced overexpression of PGC-1a directly in the
inguinal white fat of mice using adenoviral delivery. Even the
modest level of overexpression achieved (z50% increase over
basal) was sufficient to induce thermogenic gene expression in
this depot in wild-type mice. BATI4KO mice, however, did not
show this effect, demonstrating definitively that PGC-1a is not
thermogenic in the absence of IRF4 (Figure 7F). Our data thus
strongly suggest a model in which PGC-1a and IRF4 induce
each other’s expression and then interact physically to fully acti-
vate Ucp1 (Figure 7G).
DISCUSSION
Adaptive (nonshivering) thermogenesis relies upon the success-
ful execution of a defined program of gene expression in
response to ambient conditions, centered on Ucp1. In general,
transcription requires the concerted actions of sequence-spe-
cific DNAbinding proteins as well as a large number of cofactors,
which do not themselves bind to DNA. These cofactors can acti-
vate or repress transcription, depending upon their ability to
recruit specific chromatin-modifying enzymes to the locus being
regulated. Interestingly, while a few sequence-specific transcrip-
tion factors that play a role in brown fat differentiation and func-
tion have been identified, such as PPARa, PPARg, C/EBPb,
EBF2, and ERRa, a much larger number of cofactors have
been described (Kajimura et al., 2010; Rajakumari et al., 2013).(E) Continuousmeasurement of oxygen consumption rate (OCR) in isolated mitoc
was performed under basal conditions, following the addition of oligomycin (14
inhibitor antimycin A and rotenone (4 mM each) (n = 10–12, *p < 0.05).
(F) Lipid handling and general adiposemarker gene expression in BAT. RNAwas h
23C. Gene expression was measured using qPCR. Data are normalized to 36B
(G) Rectal temperature of control and BATI4OE mice during acute cold exposure
for AUC).
See also Figure S3.These include pocket proteins like pRb and p107, but also
SRC-1, SRC-2, SRC-3, TRIP-Br2, RIP140, and most notably,
PRDM16 and PGC-1a (Kajimura et al., 2010; Liew et al., 2013;
Puigserver and Spiegelman, 2003). The challenge, then, has
been to identify the transcriptional partners through which these
cofactors act to promote their activities.
Most of the published data on transcription and brown fat
relate to the processes of development and the establishment
of brown fat identity. Our work focuses instead on the transcrip-
tional basis for thermogenic function in already differentiated
brown and beige adipocytes. Specifically, the use of Ucp1-Cre
mice to target ablation or overexpression of IRF4 requires that
brown fat identity be already established. We have previously
shown that IRF4 is moderately antiadipogenic (Eguchi et al.,
2008); the actions we have focused on here and in our prior
work in which we knocked out Irf4 using an adiponectin-Cre
deletor strain (Eguchi et al., 2011) are studies of adipocyte phys-
iology, not specification or differentiation.
Brown and beige adipocytes are defined in part by their rich
complement of mitochondria. PGC-1a is a major driver of
mitochondrial biogenesis and function, subserving this function
through interactions with ERRa and NRF-2 (Gigue`re, 2008).
IRF4 does not promote mitochondrial gene expression when
overexpressed in brown adipocytes, although we do see
significantly reduced gene expression when IRF4 is ablated,
associated with reduced oxygen consumption. Even in this
condition, however, there is no change in mitochondrial number
or appearance. This suggests that the interaction of PGC-1a and
IRF4 to promote thermogenesis is distinct from an effect on
mitochondrial biogenesis. In contrast, IRF4 is both necessary
and sufficient to promote the fatty acid oxidation gene program,
including expression of the dominant transcription factor of that
process, PPARa.
We previously showed that loss of IRF4 in all fat (using the
adiponectin-Cre line) diminishes isoproterenol-stimulated glyc-
erol release by 30%–50% (Eguchi et al., 2011), an effect seen
both ex vivo and in vivo. Somewhat surprisingly, in the present
work, loss of IRF4 restricted to Ucp1+ cells has a quantitatively
similar effect on lipolysis (Figures S5B and S5C). Taken at face
value, this suggests that BAT is the dominant source of liberated
glycerol after a catecholamine challenge, despite the fact that
BAT represents a small percentage of total fat mass. In fact,
this may be a reasonable expectation, given that the b-adren-
ergic receptors Adrb1, Adrb2, and Adrb3 are all expressed to
a greater degree in BAT than in WAT (http://biogps.org); isopro-
terenol is a nonselective agonist of all three subtypes. Thus, BAT
may be poised to transduce the catecholaminergic signal much
more rapidly than WAT, and elevated glycerol levels in the first
few hours after adrenergic stimulation may derive almost entirelyhondria from BAT of BATI4OE and control mice on chow. Oxygen consumption
mM), the pharmacological uncoupler FCCP (10 mM) or the Complex III and I
arvested fromBAT of BATI4OE and control littermates after 28weeks onHFDat
4 and expressed as mean ± SEM (n = 3–5, *p < 0.05).
(4C). Results are expressed as mean ± SEM (n = 6 mice per group, *p < 0.05
Cell 158, 69–83, July 3, 2014 ª2014 Elsevier Inc. 75
re
la
tiv
e 
m
R
N
A 
le
ve
ls
0.0
0.5
1.0
1.5 Flox
KO
*
Irf4
BAT        iWAT      eWAT      spleen
0.0
0.5
1.0
1.5
2.0
re
la
tiv
e 
m
R
N
A 
le
ve
ls
Irf4
*
* *
Flox         KO          Flox            KO           Flox             KO
eWAT iWAT BAT
IRF4
actin
Fat mass Lean mass
0
5
10
15
20
25
*
G
ra
m
s
0 1 2 3 4 5 6 7 8 9 10 11 12
20
25
30
35
40
45
50
55
60
Flox
KO
Cre
*
weeks on HFD
B
od
y 
w
ei
gh
t (
g)
Flox                 KO
iWAT
eWAT
Flox       KO Flox  KO
Food intake
Cre Flox KO0
1
2
3
gr
am
/d
ay
/m
ou
se
dark light
Flox
KO
p<0.0001
O2 consumption
2000
2500
3000
3500
4000
4500
5000
VO
2(
m
l/k
g/
hr
)
p<0.0001
Flox
KO
1500
2000
2500
3000
3500
4000
VC
O
2(
m
l/k
g/
hr
)
A B
C D
E F G
H I J
Figure 4. Mice Lacking IRF4 in Brown Adipose Tissue Have Reduced Energy Expenditure
(A) Irf4 mRNA expression was measured by qPCR in BAT from HFD, ob/ob, and db/db mice (n = 3–5; *p < 0.05).
(B) Irf4 expression in different tissues of BATI4KO and control mice (n = 4; *p < 0.05).
(C) Western blot analysis of IRF4 protein levels in various adipose depots from mice in (B).
(D) Body weights of male Cre only, Flox only and BATI4KO (KO) mice on HFD (n = 8–19).
(E) Body composition of the mice from (C) (*p < 0.05).
(F) Gross morphology of BATI4KO mice (30 weeks old) and inguinal and epididymal fat pads.
(G) Hematoxylin and eosin staining of inguinal and epididymal WAT sections from 30-week-old mice (320).
(legend continued on next page)
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from brown adipocytes. Perhaps depletion of BAT lipid stores
might occur with longer periods of fasting, cold, or adrenergic
agonist administration, allowing WAT to become the dominant
source of lipolytic products. Testing this hypothesis will require
careful tracer studies to identify the source of serum glycerol
after a lipolytic provocation.
Our previous work also demonstrated that IRF4 was antili-
pogenic in white fat, such that loss of IRF4 in white adipocytes
increased expression of such key lipid synthesis genes as
Scd1, Fasn, and Srebf1. Concordant with this, loss of IRF4
enhanced 14C-glucose incorporation into lipid and add-back
of IRF4 repressed this (Eguchi et al., 2011). In the current
study, we find that loss of IRF4 in brown fat also increases
lipid synthesis from glucose and overexpression inhibits it.
However, we see no concomitant change in lipogenic expres-
sion in either the gain-of-function or loss-of-function models to
explain this. Possibly there are differences in levels of lipo-
genic enzyme protein or activity, or perhaps IRF4 is exerting
its primary effects at the level of lipolysis and fatty acid oxida-
tion, and the changes in lipid synthesis simply reflect altered
substrate availability.
IRF4, unlike many other IRFs, is regulated strongly at the tran-
scriptional level. In our previous work, we demonstrated that
expression of Irf4 mRNA is induced by fasting in both brown
and white adipocytes (Eguchi et al., 2011). This effect is due to
the drop in insulin levels that occurs in the fasted state, allowing
FoxO1 to remain in the nucleus, where it drives the Irf4 promoter.
Interestingly, Ortega-Molina et al. (2012) recently showed that
mice overexpressing Pten have enhanced FoxO1 activity and
are lean with increased Ucp1 and Ppargc1a expression. Could
FoxO1 be activated by cold and thus serve as the upstream
effector of IRF4 expression in BAT? A recent report demon-
strates that FoxO1 is induced by 24 hr of cold exposure in rat
muscle, with a subsequent increase in proteolysis (Manfredi
et al., 2013). Thus, FoxO1 is an excellent candidate for a cold-
inducible activator of IRF4 and subsequent thermogenesis.
Other factors may also be at play, such as CREB, which medi-
ates many of the transcriptional effects of cAMP (Altarejos and
Montminy, 2011). Interestingly, a recent paper suggests that
IRF4 acts upstream of CREB, at least in cardiac muscle (Jiang
et al., 2013).
IRF4 plays a wide variety of roles in the immune system,
including critical functions in macrophage polarization (Eguchi
et al., 2013; Satoh et al., 2010), plasma cell differentiation (Klein
et al., 2006; Sciammas et al., 2006), regulatory T cell function
(Cretney et al., 2011; Zheng et al., 2009), and the differentiation
of CD4+ and CD8+ T cells (Bru¨stle et al., 2007; Kwon et al.,
2009; Man et al., 2013; Raczkowski et al., 2013; Staudt et al.,
2010; Yao et al., 2013). By and large, these studies have
focused on a limited subset of IRF4 target genes that control
immune cell differentiation, without considering a possible role
for IRF4 as a regulator of energy metabolism, despite a long-(H) Food intake was measured daily after 20 weeks on HFD (n = 8), and cumulat
(I and J) O2 consumption and CO2 production rates of BATI4KO and control litter
HFD (n = 8; *p < 0.0001 for both).
See also Figure S4.standing appreciation of the enormous energy requirements
inherent in mounting a coherent immune response (Odegaard
and Chawla, 2013). One recent paper, however, did report
that energy metabolism genes were direct targets of IRF4 in
cytotoxic CD8+ T cells and even suggested that IRF4 ablation
in these cells resulted in a reduced oxygen consumption rate
(Man et al., 2013), consistent with what we find in brown adi-
pose tissue. There has not been significant investigation into
the role of PGC-1a in lymphocyte biology, although it is ex-
pressed in these cells (http://biogps.org), and one study does
suggest a possible role for PGC-1a in regulating intralympho-
cyte antioxidant levels after exercise (Ferrer et al., 2009). In
macrophages, the related coactivator PGC-1b is induced by
Th2 cytokines like IL-4, promoting oxidative metabolism and
reduced inflammatory gene expression. It is unknown whether
IRF4 interacts with PGC-1b, although this isoform does possess
similar LXXLL domains as PGC-1a and is able to coactivate
nuclear receptors (Meirhaeghe et al., 2003). Our results demon-
strate that IRF4, alone or in combination with PGC-1a, is a tran-
scriptional regulator of cellular metabolism and support deeper
investigation of this as a possible mechanism by which it acts in
immune cells.
Transcriptional regulation of the Ucp1 gene has been studied
extensively. Early studies by Kozak et al. (1994) and Larose et al.
(1996) focused on an 200 bp region located 2.5 kb upstream
of the Ucp1 transcriptional start site. This area, originally defined
by DNase I hypersensitivity, contains binding sites for transcrip-
tion factors that mediate brown fat specification (PPARg, EBF2)
aswell as cold and norepinephrine-induced thermogenesis (e.g.,
TR, CREB) (Boyer and Kozak, 1991; Kozak et al., 1994; Larose
et al., 1996; Rajakumari et al., 2013). Here, we isolate an inter-
feron-stimulated response element (ISRE) mediating at least
part of the IRF4 response that is separate from this narrowly
defined enhancer. This region falls outside of all previously
identified 50 flanking DNase hypersensitivity regions (Boyer and
Kozak, 1991), but it should be noted that more recent studies
from the mouse ENCODE consortium indicate that the entire
10 kb region proximal to the Ucp1 TSS is heavily decorated by
H3K4me1, H3K4me3, and H3K27acmarks in brown adipose tis-
sue (https://genome.ucsc.edu/ENCODE/dataSummaryMouse.
html). This indicates that a much larger region of this locus
is characterized by open chromatin than has previously been
appreciated.
Finally, it is worth remembering that nonshivering thermo-
genesis requires the coordinated activities of several different
tissues. Cold must be sensed and signals sent via the sympa-
thetic nervous system to release catecholamines, which acti-
vate b-adrenergic receptors in brown fat. Lipolysis in white
fat must also occur to generate the fatty acid substrate
required to fuel mitochondrial activity. Alternatively activated
(so-called M2) macrophages have recently been proposed
to participate in thermogenesis via their own elaboration ofive food intake was calculated after 3 days.
mates were measured by indirect calorimetry using CLAMS after 22 weeks on
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Figure 5. BATI4KO Mice Display Decreased Thermogenic Gene Expression and Cold Intolerance
(A) Gross appearance of interscapular BAT from control and BATI4OE mice at RT.
(B) Hematoxylin and eosin staining of BAT sections from mice housed at 23C or 4C for 6 hr.
(C) Thermogenic, mitochondrial and fatty acid oxidation gene expression in BAT. RNA was harvested from BAT of BATI4KO or control littermates after 22 weeks
on HFD. Gene expression was measured using qPCR. Data are normalized to 36B4 and expressed as mean ± SEM (n = 3–5, *p < 0.05).
(D) Western blot analysis of protein in BAT of mice in (C).
(legend continued on next page)
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Figure 6. Cold and b3-Agonist Cannot Induce Thermogenic Expression in the Absence of IRF4
(A) RNA was harvested from interscapular BAT of BATI4KO or control littermates housed at 23C or 4C for 6 hr. Gene expression was measured using qPCR.
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expressed as mean ± SEM (n = 3–5, *, versus WT saline, p < 0.05; #, versus WT CL, p < 0.05).catecholamines (Nguyen et al., 2011). IRF4 has now been
shown to be a key regulator of all of these processes: it is
required for lipolysis in white fat (Eguchi et al., 2011) and for
M2 polarization of macrophages (Eguchi et al., 2013; Satoh
et al., 2010), and we now show that there is a direct effect of
IRF4 on thermogenic gene expression in BAT. Taken together,
these data establish IRF4 as a central actor in adaptive thermo-
genesis, acting to coordinate the activities of multiple tissues to
generate heat.(E) Lipid handling and general adipose marker gene expression in BAT. RNA was
Gene expression was measured using qPCR. Data are normalized to 36B4 and
(F) Total respiration in BAT measured by Clark electrode (n = 4, *p < 0.05).
(G) Continuous measurement of oxygen consumption rate (OCR) in isolatedmitoc
was performed under basal conditions, following the addition of oligomycin (14
inhibitor antimycin A and rotenone (4 mM each) (n = 7–13, *p < 0.05).
(H) Rectal temperature of control and BATI4KOmice during cold exposure (4C). R
per group).
See also Figures S5 and S6.EXPERIMENTAL PROCEDURES
Antibodies
Antibodies were purchased from Santa Cruz Biotechnology (IRF4, sc-6059;
actin, sc-1615; PGC-1a, sc-13067), Abcam (UCP1, AB10983; Mito profile,
AB110413; Aconitase, AB110321), and Millipore (PGC-1a, ST1202-1SET).
Animals
Miceweremaintainedundera12hr light/12hrdarkcycleatconstant temperature
(23C) with free access to food and water. All animal studies were approved byharvested from BAT of BATI4KO or control littermates after 22 weeks on HFD.
expressed as mean ± SEM (n = 3–5, *p < 0.05).
hondria from BAT of BATI4KO and control mice on chow. Oxygen consumption
mM), the pharmacological uncoupler FCCP (10 mM) or the Complex III and I
esults are expressed asmean ±SEM, *p < 0.05 relative to Floxmice (n = 6mice
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Figure 7. PGC-1a Interacts with IRF4 and
Enhances Its Transcriptional Activity
(A) Coimmunoprecipitation of PGC-1a-FLAG and
IRF4 expressed in 293 cells.
(B) Coimmunoprecipitation of endogenous PGC-1a
and IRF4 in BAT of WT mice. Mice were exposed to
4C for 6 hr and then sacrificed for BAT protein
extraction; data represent pooled BAT from five
animals.
(C) Direct interaction between PGC-1a and IRF4 by
GST-pull down assay.
(D) Fragments of the Ucp1 promoter fused to a
luciferase reporter gene were cotransfected into 293
cells together with pCDH-GFP (control) or IRF4 in the
presence or absence of a PGC-1a expression
plasmid. Luciferase activity was corrected for Renilla
luciferase activity and normalized to control activity
(n = 3, *p < 0.05).
(E) ChIP analysis in BAT from BATI4OE mice. The
signal in IgG is set as 1. Results are expressed as
mean ± SD (n = 3, *p < 0.05).
(F) Adenovirus expressing PGC-1a or lacZ was in-
jected into the inguinal fat pad of control or BATI4KO
mice (n = 3–6, *p < 0.05).
(G) Model of how PGC-1a and IRF4 interact at the
genetic, physical, and functional levels to promote
thermogenic gene expression.
See also Figure S7.the Institutional Animal Care andUse Committee of Beth Israel DeaconessMed-
ical Center. For determination of IRF4 expression in fat depots from mice
exposed to cold, mice were housed at 4C for up to 6 days. The 16-week-old
ob/ob and db/db mice were purchased from Jackson Laboratories. For DIO
studies,C57BL/6Jmicewere fedanHFD (D12331;ResearchDiets) for 12weeks.
Cold-Induced Thermogenesis
Mice were placed in a cold chamber (4C) for up to 1 week. Body temperature
was measured using a rectal probe (Yellow Spring Instruments).
Indirect Calorimetry
Metabolic rate was measured by indirect calorimetry in open-circuit Oxymax
chambers, a component of the Comprehensive Lab AnimalMonitoring System
(CLAMS; Columbus Instruments). Mice were housed individually and main-
tained at 23C under a 12 hr light/12 hr dark cycle. Food and water were avail-
able ad libitum.80 Cell 158, 69–83, July 3, 2014 ª2014 Elsevier Inc.Glucose and Insulin Tolerance Tests
For glucose tolerance tests (GTTs), mice were fasted
overnight. Glucose (2 g/kg) was administered intra-
peritoneally (i.p.), and blood glucose levels were
measured at 0, 15, 30, 60, and 120 min. Serum insu-
lin was measured during the GTT at the 0, 15, and
60 min time points. For the insulin tolerance test
(ITT), mice were fasted for 6 hr. Insulin (0.7 U/kg for
chow diet and 0.8 U/kg for HFD) was administered
i.p., and blood glucose was measured at 0, 15, 30,
60, and 120 min.
Determination of Cellular Respiration
Tissue respiration was performed using a Clark
electrode (Strathkelvin Instruments). Freshly isolated
BAT was isolated, rinsed in sterile saline, weighed,
minced, and placed into respiration buffer, and
readings were taken with three separate pieces of
tissue of equivalent size. Oxygen consumption was
normalized to tissue weight. For Seahorse studies,BAT mitochondria were isolated in STE buffer, pH 7.4 (250 mM sucrose,
5 mM Tris, 2 mM EGTA). Mitochondria were resuspended in assay buffer
(50 mM KCl, 4 mM KH2PO4, 5 mM HEPES, and 1 mM EGTA, 4% BSA,
10 mM Pyruvate, 5 mM Malate). Oxygen consumption rate (OCR) of BAT
mitochondria (5 mg) was determined using an XF24 Extracellular Flux
Analyzer (Seahorse Bioscience). Uncoupled and maximal OCR was deter-
mined using oligomycin (14 mM) and FCCP (10 mM). Antimycin A and rotenone
(4 mM each) were used to inhibit Complex III- and Complex I-dependent
respiration.
Luciferase Reporter Assays
The mouse Ucp1 promoter was amplified and inserted into the KpnI and XhoI
sites of pGL3-basic (Promega). HEK293T cells were cultured in 24-well plates
and cotransfected with PGC-1a plasmid (0.2 mg/well), IRF4 plasmid (0.2 mg/
well), luciferase reporter construct (0.2 mg/well), and galactosidase expression
vector (control reporter) (0.006 mg/well) with the Profection kit (Promega),
according to the manufacturer’s protocol. The mass of transfected plasmids
was balanced with empty vector (pCDH-EGFP). After 48 hr, cells were har-
vested and measured using the Dual-Luciferase Reporter assay system
(Promega), and luciferase activity was divided by Renilla luciferase activity
(control reporter) to normalize for transfection efficiency. Alternatively, SVFs
were extracted from BAT and then 6 days after adipogenic stimulation,
adipocytes were detached with trypsin and transfected using the Amaxa nu-
cleofection system (Amaxa Biosystems). Transfections were performed with
1 mg reporter construct along with 0.5 mg IRF4-pCDH expression vector,
1 mg pcDNA- PGC-1a, with 25 ng galactosidase expression vector. After
48 hr, cells were harvested and measured using the Dual-Luciferase Reporter
assay system (Promega). All luciferase assay experiments were performed
three times at least and each conducted in triplicate.
Chromatin Immunoprecipitation
Nuclei were extracted from BAT of BATI4OE mice and then treated with 1%
formaldehyde for 4 min at room temperature to crosslink DNA-protein com-
plexes. Genomic DNA was sheared with a Sonic Dismembrator Model 100
(Fisher Scientific) to obtain fragments ranging from 200 bp to 1 kb. Chromatin
immunoprecipitation (ChIP) was performed with a kit from Upstate, with 10 mg
primary antibody from Santa Cruz (goat anti-iRF4; sc-6059) or goat IgG.
Crosslinking was reversed, and purified DNA was subjected to qPCR with
SYBR green fluorescent dye (Stratagene).
Protein Extraction and Western Blot Analysis
Protein was extracted from BAT by using RIPA buffer (Boston BioProducts)
supplemented with complete protease inhibitor cocktail (Roche). For western
blot analyses, 60 mg protein was subjected to SDS-PAGE under reducing
conditions, transferred, and blotted with an appropriate antibody.
Coimmunoprecipitation Studies
HEK293T cells were transfected with IRF4, PGC-1a, or both. Cell lysates were
collected in RIPA buffer 48 hr after transfection. IRF4 protein was immunopre-
cipitated using anti-iRF4 antibody (sc-28696; Santa Cruz). IRF4 was western
blotted using anti-iRF4 antibody (sc-6059; Santa Cruz) and anti-PGC-1a
antibody (AB3242; Millipore).
GST-Pull-Down
GST-PGC-1a vector was a gift from Pere Puigserver and was transformed into
BL21 (NEB) to express the protein. IRF4 was synthesized using a TNT-coupled
in vitro transcription/translation system (Promega). The resultant protein was
incubated with GST-PGC-1a and then immobilized on glutathione-Sepharose
beads according to the manufacturer’s instructions (Thermo). Proteins were
eluted by glutathione and analyzed by western blotting.
Analysis of Gene Expression by qPCR
Total RNA was extracted from tissues with TRIzol reagent (Invitrogen) accord-
ing to the manufacturer’s instructions. 1 mg total RNA was converted into first-
strand cDNA with oligo(dT) primers as described by the manufacturer
(Clontech). PCR was performed in an Mx3000P Q-PCR system (Stratagene)
with specific primers and SYBR Green PCRMaster Mix (Stratagene). The rela-
tive abundance of mRNAs was standardized with 36B4 mRNA as the invariant
control.
Adenovirus Production, Purification, and Injection
The adenoviral expression vector pAD/CMV/V5-DEST (Invitrogen) encoding
cDNA for PGC-1a and Lac Z were constructed as per manufacturer’s
protocol. Crude adenovirus were amplified twice and then purified using
the Vivapure adenopack-100 purification kit (Sartorius Stedim). Adenovirus
titer was calculated using Adeno-X Rapid Titer kit (Clontech). For fat pad
injections, Lac Z or PGC-1a adenovirus (1 3 1010 infectious units/mice)
were injected subcutaneously into the inguinal fat pad in a total volume
of 50 ml.
Statistical Analysis
Unpaired two-tailed Student’s t tests and two-way ANOVAwere used. p < 0.05
was considered statistically significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.04.049.
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